Microbiota, obesity and NAFLD

65Citations
Citations of this article
111Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Non-alcoholic fatty liver disease (NAFLD) is an increasingly important cause of chronic liver disease globally. Similar to metabolic syndrome and obesity, NAFLD is associated with alternations in the gut microbiota and its related biological pathways. While the exact pathophysiology of NAFLD remains largely unknown, changes in intestinal inflammation, gut permeability, energy harvest, anaerobic fermentation and insulin resistance have been described. In this chapter, we review the relationship between the gut microbiota, obesity and NAFLD, and highlight potential ways to modify the gut microbiota to help managing NAFLD patients.

Cite

CITATION STYLE

APA

Lau, L. H. S., & Wong, S. H. (2018). Microbiota, obesity and NAFLD. In Advances in Experimental Medicine and Biology (Vol. 1061, pp. 111–125). Springer New York LLC. https://doi.org/10.1007/978-981-10-8684-7_9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free